MSP Recovery EBIT 2020-2024 | MSPR
MSP Recovery ebit from 2020 to 2024. Ebit can be defined as earnings before interest and taxes.
| MSP Recovery Annual EBIT (Millions of US $) |
|
|---|---|
| 2024 | $-1,274 |
| 2023 | $-560 |
| 2022 | $-331 |
| 2021 | $-7 |
| 2020 | $-3 |
| 2019 | $0 |
| MSP Recovery Quarterly EBIT (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-879 |
| 2024-09-30 | $-130 |
| 2024-06-30 | $-135 |
| 2024-03-31 | $-130 |
| 2023-12-31 | $-142 |
| 2023-09-30 | $-137 |
| 2023-06-30 | $-141 |
| 2023-03-31 | $-141 |
| 2022-12-31 | $-136 |
| 2022-09-30 | $-125 |
| 2022-06-30 | $-67 |
| 2022-03-31 | $-3 |
| 2021-12-31 | $-2 |
| 2021-09-30 | $-3 |
| 2021-06-30 | $-2 |
| 2021-03-31 | $0 |
| 2020-12-31 | |
| 2020-09-30 | $0 |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.016B | $0.018B |
| MSP Recovery LLC. is a medicare, medicaid, commercial and secondary payer reimbursement recovery leader. It provides the healthcare industry with comprehensive compliance solutions. MSP Recovery LLC., formerly known as Lionheart Acquisition Corporation II, is based in CORAL GABLES, Fla. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.476B | 53.14 |
| Tempus AI (TEM) | United States | $9.826B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $9.069B | 145.79 |
| Inspire Medical Systems (INSP) | United States | $4.756B | 92.38 |
| IRhythm Technologies (IRTC) | United States | $4.186B | 0.00 |
| Privia Health (PRVA) | United States | $2.829B | 212.00 |
| Enovis (ENOV) | United States | $2.016B | 12.47 |
| Schrodinger (SDGR) | United States | $1.847B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.706B | 0.00 |
| Phreesia (PHR) | United States | $1.512B | 0.00 |
| Omnicell (OMCL) | United States | $1.460B | 31.48 |
| Azenta (AZTA) | United States | $1.232B | 57.36 |
| 10x Genomics (TXG) | United States | $1.031B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.634B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.566B | 0.00 |
| Talkspace (TALK) | United States | $0.537B | 319.00 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Standard BioTools (LAB) | United States | $0.456B | 0.00 |
| TruBridge (TBRG) | United States | $0.392B | 0.00 |
| Claritev (CTEV) | United States | $0.362B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.294B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.208B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.202B | 0.00 |
| Pulmonx (LUNG) | United States | $0.152B | 0.00 |
| American Well (AMWL) | United States | $0.116B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.085B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.081B | 0.00 |
| CareCloud (CCLD) | United States | $0.080B | 3.43 |
| 111 (YI) | China | $0.072B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| Precipio (PRPO) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |